IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
|
05.05.2026 12:37:51
|
IDEXX Laboratories Inc Q1 Income Climbs
(RTTNews) - IDEXX Laboratories Inc (IDXX) released a profit for its first quarter that Increases, from the same period last year
The company's bottom line totaled $278.45 million, or $3.47 per share. This compares with $242.68 million, or $2.96 per share, last year.
Excluding items, IDEXX Laboratories Inc reported adjusted earnings of $3.30 per share for the period.
The company's revenue for the period rose 14.2% to $1.140 billion from $998.43 million last year.
IDEXX Laboratories Inc earnings at a glance (GAAP) :
-Earnings: $278.45 Mln. vs. $242.68 Mln. last year. -EPS: $3.47 vs. $2.96 last year. -Revenue: $1.140 Bln vs. $998.43 Mln last year.
-Guidance: Full year EPS guidance: $ 14.45 To $ 14.90 Full year revenue guidance: $ 4675 M To $ 4760 M
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratories
Analysen zu IDEXX Laboratories
Aktien in diesem Artikel
| IDEXX Laboratories | 484,40 | -0,47% |
|